Checkpoint Therapeutics Inc (CKPT)
3.735
+0.26
(+7.64%)
USD |
NASDAQ |
Nov 22, 16:00
3.72
-0.02
(-0.40%)
After-Hours: 20:00
Checkpoint Therapeutics Revenue (Quarterly)
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 0.041M |
| March 31, 2024 | |
| December 31, 2023 | 0.006M |
| September 30, 2023 | 0.031M |
| June 30, 2023 | 0.031M |
| March 31, 2023 | 0.035M |
| December 31, 2022 | 0.074M |
| September 30, 2022 | 0.048M |
| June 30, 2022 | 0.018M |
| March 31, 2022 | 0.052M |
| December 31, 2021 | 0.016M |
| September 30, 2021 | 0.029M |
| June 30, 2021 | 0.155M |
| March 31, 2021 | 0.068M |
| December 31, 2020 | 0.027M |
| September 30, 2020 | 0.028M |
| June 30, 2020 | 0.042M |
| March 31, 2020 | 0.972M |
| Date | Value |
|---|---|
| December 31, 2019 | 0.025M |
| September 30, 2019 | 0.28M |
| June 30, 2019 | 1.051M |
| March 31, 2019 | 0.352M |
| December 31, 2018 | 3.031M |
| September 30, 2018 | 0.005M |
| June 30, 2018 | 0.127M |
| March 31, 2018 | 0.343M |
| December 31, 2017 | 0.332M |
| September 30, 2017 | 0.349M |
| June 30, 2017 | 0.351M |
| March 31, 2017 | 0.693M |
| December 31, 2016 | 0.498M |
| September 30, 2016 | 0.546M |
| June 30, 2016 | 1.249M |
| March 31, 2016 | 0.277M |
| December 31, 2015 | 0.065M |
| September 30, 2015 | 0.025M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
0.006M
Minimum
Dec 2023
0.972M
Maximum
Mar 2020
0.0943M
Average
0.033M
Median
Revenue (Quarterly) Benchmarks
| Fortress Biotech Inc | 14.63M |
| NovaBay Pharmaceuticals Inc | 2.441M |
| Palatin Technologies Inc | -- |
| iBio Inc | -- |
| Theriva Biologics Inc | -- |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -9.725M |
| Total Expenses (Quarterly) | 9.724M |
| EPS Diluted (Quarterly) | -0.23 |
| Enterprise Value | 164.75M |
| Earnings Yield | -49.26% |
| Normalized Earnings Yield | -44.76 |